{"id":128005,"date":"2021-04-05T15:00:44","date_gmt":"2021-04-05T12:00:44","guid":{"rendered":"https:\/\/ldaily.ua\/?post_type=news&#038;p=128005"},"modified":"2021-04-05T15:31:52","modified_gmt":"2021-04-05T12:31:52","slug":"problemy-z-vakczynoyu-obvalyly-akcziyi-postachalnyka-johnson-johnson-na-145","status":"publish","type":"news","link":"https:\/\/ldaily.ua\/en\/news\/novosti\/problemy-z-vakczynoyu-obvalyly-akcziyi-postachalnyka-johnson-johnson-na-145\/","title":{"rendered":"Vaccine problems knock down Johnson &#038; Johnson shares by 14.5%"},"content":{"rendered":"<p>Johnson &#038; Johnson has found a batch of coronavirus vaccine that does not meet quality standards, the company said. Supplier Emergent BioSolutions at a plant in Baltimore manufactured the batch. This batch was not poured into ampoules and was not admitted to the final stages of production, the report said.<\/p>\n<p>&nbsp;<\/p>\n<p>Against this background, shares of Emergent BioSolutions on the New York Stock Exchange fell 14.56% to $ 79. Shares of Johnson &#038; Johnson fell 1.1% to $ 162.55 per share.<\/p>\n<p>The Food and Drug Administration (FDA) have not yet certified emergent BioSolutions for the Johnson &#038; Johnson vaccine. Due to the incident, the regulator began inspecting the plant.<\/p>\n<p>Emergent BioSolutions is a partner of Johnson &#038; Johnson and AstraZeneca. According to The New York Times, workers at the subcontractor&#8217;s factory accidentally mixed ingredients from Johnson &#038; Johnson and AstraZeneca coronavirus vaccines. After that, Johnson &#038; Johnson tightened control over the work of Emergent BioSolutions to avoid additional losses, the publication said.<\/p>\n<p>A manufacturing error at a coronavirus vaccine plant resulted in the loss of 15 million doses of Johnson &#038; Johnson, Bloomberg reported, citing two sources familiar with the situation.<\/p>\n<p>The coronavirus vaccine, developed by Johnson &#038; Johnson, was approved in the United States in February. Johnson &#038; Johnson has become the third vaccine approved for use in the United States in an emergency. It requires only one injection. The company intends to supply 100 million single-dose vaccines to the United States in the first half of 2021. By the end of the year, Johnson &#038; Johnson expects to deliver more than one billion doses of the vaccine.<\/p>\n","protected":false},"featured_media":128007,"menu_order":0,"template":"","newscat":[9],"newstag":[],"issues":[],"class_list":["post-128005","news","type-news","status-publish","has-post-thumbnail","hentry","newscat-novosti"],"_links":{"self":[{"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/news\/128005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/media\/128007"}],"wp:attachment":[{"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/media?parent=128005"}],"wp:term":[{"taxonomy":"newscat","embeddable":true,"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/newscat?post=128005"},{"taxonomy":"newstag","embeddable":true,"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/newstag?post=128005"},{"taxonomy":"issues","embeddable":true,"href":"https:\/\/ldaily.ua\/en\/wp-json\/wp\/v2\/issues?post=128005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}